AYR-A.CN Ayr Wellness (CNQ) Feb 2026 market hours: Oversold bounce to C$0.28

The AYR-A.CN stock opened market hours at C$0.155 and is trading near its 52-week low, setting up an oversold bounce candidate for active traders. Volume is light at 105015.00 shares versus an average of 127878.00, which raises liquidity risk but allows sharp short-term moves. With a 50-day average of C$0.28 and a 200-day average of C$1.08, the price sits well below key moving averages. Upcoming earnings on 2026-03-04 add a near-term catalyst that could trigger a technical rebound or further weakness.

AYR-A.CN stock: Market snapshot and trading facts

AYR-A.CN stock is quoted on the CNQ exchange in Canada at C$0.155 with a day low/high of C$0.15/C$0.16. Market cap is C$18099910.00 and shares outstanding are 116773612.00. The year high is C$3.60 and the year low is C$0.12, showing extreme range compression after heavy declines. Average volume sits at 127878.00, and the current relative volume is 0.82, so intraday moves can be amplified when flows hit the tape.

Fundamentals and valuation for AYR-A.CN stock

Ayr Wellness (AYR-A.CN) reports trailing EPS of -4.45 and a negative PE of -0.03, reflecting continuing losses. Key ratios show low price-based valuation: price-to-sales 0.04 and price-to-book 0.04. Balance-sheet metrics show leverage with debt-to-equity near 1.96 and a current ratio around 0.49, indicating tight short-term liquidity. These fundamentals explain the depressed share price and increase downside risk despite low nominal market cap.

Technicals: why this is an oversold bounce setup for AYR-A.CN stock

Technically, AYR-A.CN stock sits 44.03% below its 50-day average (C$0.28) and 85.68% below its 200-day average (C$1.08), a classic oversold distance that can produce mean-reversion bounces. The recent three-month price change is about -13.89%, and six-month change is -80.86%, showing extended selling. Low liquidity increases stop-hunt risk, so a bounce trade should require a clear trigger such as a close above C$0.18 or a volume spike above 127878.00 shares to confirm demand.

Meyka AI rates AYR-A.CN with a score out of 100 and forecast

Meyka AI rates AYR-A.CN with a score of 68.21/100, grade B (HOLD). This grade factors S&P 500 and sector comparisons, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a base-case bounce to C$0.28, a bull scenario to C$0.60, and a downside floor near C$0.12. Compared to the current C$0.155, the model implies a base-case upside of 80.65%, bull upside of 287.10%, and bear downside of -22.58%. Forecasts are model-based projections and not guarantees.

Catalysts, sector context and headline risk for AYR-A.CN stock

Catalysts that could drive a bounce include the upcoming earnings report on 2026-03-04, short-covering events, and any state-level regulatory wins for the cannabis sector. The healthcare sector is mixed; drug manufacturers face margin pressure and slow growth versus other industries, which weighs on AYR-A.CN stock. Watch short-interest notes and recent market commentary for sudden squeezes MarketBeat short interest. Broader investor analysis appears on platforms like Seeking Alpha for longer reads Seeking Alpha analysis.

Trading plan: oversold bounce strategy for AYR-A.CN stock

A defined plan helps manage risk on AYR-A.CN stock. Consider a small, tactical position only after a confirmed volume breakout (daily volume > 130000.00) or a clean close above C$0.18. Set a tight stop-loss near C$0.12 and a first profit target at C$0.28 (Meyka base), with a secondary target at C$0.60 for aggressive traders. Limit position size to a small portfolio allocation due to high volatility and weak fundamentals.

Final Thoughts

AYR-A.CN stock presents an oversold bounce trade rather than a value buy. At C$0.155 the shares are deeply below short- and long-term moving averages, creating scope for a short-term mean reversion. Meyka AI’s model projects a base-case rebound to C$0.28 (implied upside 80.65%), while a bull case reaches C$0.60 and a bear floor sits near C$0.12. Traders should treat this as a high-risk, event-driven setup: confirm with volume, manage position size, and use stops. Fundamental headwinds—negative EPS -4.45, weak current ratio 0.49, and elevated debt-to-equity 1.96—mean any bounce could be short lived without sustainable earnings improvement. Use the 2026-03-04 earnings release and short-interest flow as near-term decision points. Meyka AI provides this as data-driven analysis, not investment advice, and forecasts are model-based projections, not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.